Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Zoetis Net Profit Margin 2011-2023 | ZTS

Current and historical net profit margin for Zoetis (ZTS) from 2011 to 2023. Net profit margin can be defined as net Income as a portion of total sales revenue. Zoetis net profit margin for the three months ending December 31, 2023 was .
  
Zoetis Net Profit Margin Historical Data
Date TTM Revenue TTM Net Income Net Margin
2023-12-31 $8.54B $2.34B 27.43%
2023-09-30 $8.37B $2.28B 27.24%
2023-06-30 $8.22B $2.21B 26.92%
2023-03-31 $8.09B $2.07B 25.59%
2022-12-31 $8.08B $2.11B 26.16%
2022-09-30 $8.01B $2.07B 25.81%
2022-06-30 $8.00B $2.09B 26.14%
2022-03-31 $7.89B $2.07B 26.27%
2021-12-31 $7.78B $2.04B 26.20%
2021-09-30 $7.62B $1.98B 26.02%
2021-06-30 $7.41B $1.91B 25.76%
2021-03-31 $7.01B $1.77B 25.30%
2020-12-31 $6.68B $1.64B 24.54%
2020-09-30 $6.54B $1.66B 25.42%
2020-06-30 $6.34B $1.62B 25.50%
2020-03-31 $6.34B $1.61B 25.41%
2019-12-31 $6.26B $1.50B 23.96%
2019-09-30 $6.15B $1.46B 23.76%
2019-06-30 $6.05B $1.38B 22.74%
2019-03-31 $5.91B $1.39B 23.47%
2018-12-31 $5.83B $1.43B 24.52%
2018-09-30 $5.72B $1.16B 20.35%
2018-06-30 $5.59B $1.12B 19.95%
2018-03-31 $5.44B $0.98B 17.97%
2017-12-31 $5.31B $0.86B 16.28%
2017-09-30 $5.12B $0.94B 18.29%
2017-06-30 $5.02B $0.88B 17.50%
2017-03-31 $4.96B $0.86B 17.25%
2016-12-31 $4.89B $0.82B 16.80%
2016-09-30 $4.89B $0.69B 14.10%
2016-06-30 $4.86B $0.64B 13.15%
2016-03-31 $4.83B $0.38B 7.83%
2015-12-31 $4.77B $0.34B 7.11%
2015-09-30 $4.81B $0.44B 9.21%
2015-06-30 $4.81B $0.42B 8.74%
2015-03-31 $4.79B $0.59B 12.38%
2014-12-31 $4.79B $0.58B 12.18%
2014-09-30 $4.72B $0.56B 11.91%
2014-06-30 $4.61B $0.53B 11.43%
2014-03-31 $4.57B $0.52B 11.36%
2013-12-31 $4.56B $0.50B 11.05%
2013-09-30 $4.48B $0.39B 8.68%
2013-06-30 $4.40B $0.42B 9.55%
2013-03-31 $4.38B $0.47B 10.62%
2012-12-31 $4.34B $0.44B 10.06%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $69.491B $8.544B
Zoetis Inc. is a leader in the animal health space with a focus on both livestock and companion animals in seven major product categories: vaccines, anti-infectives, parasiticides, dermatology, other pharmaceutical products, medicated feed additives and animal health diagnostics. Zoetis has a diversified business, which caters to eight core species ' cattle, swine, poultry, fish and sheep (collectively, livestock) and dogs, cats and horses (collectively, companion animals). It directly markets its products to veterinarians and livestock producers. The outstanding growth rate in the companion animal medicines, vaccines and diagnostics sector is being driven by economic development, related increases in disposable income and a rise in pet ownership and spending on pet care.Zoetis has been working on strengthening its product portfolio through acquisitions and deals.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $53.791B 23.36
Takeda Pharmaceutical (TAK) Japan $41.617B 6.74
Merck (MKGAF) Germany $20.517B 19.36
Astellas Pharma (ALPMY) Japan $17.119B 24.26
Shionogi (SGIOY) Japan $14.091B 12.19
Neurocrine Biosciences (NBIX) United States $13.257B 55.05
Sandoz Group AG (SDZNY) Switzerland $13.249B 0.00
United Therapeutics (UTHR) United States $11.073B 11.86
Catalent (CTLT) United States $10.127B 0.00
Cerevel Therapeutics Holdings (CERE) United States $7.554B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.747B 6.84
Revolution Medicines (RVMD) United States $6.064B 0.00
Ionis Pharmaceuticals (IONS) United States $5.963B 0.00
Orion OYJ (ORINY) Finland $5.081B 21.43
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $4.918B 0.00
Madrigal Pharmaceuticals (MDGL) United States $4.543B 0.00
Alpine Immune Sciences (ALPN) United States $4.225B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.063B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.791B 0.00
Indivior (INDV) United States $2.656B 12.35
Evotec AG (EVO) Germany $2.566B 0.00
Summit Therapeutics (SMMT) United States $2.505B 0.00
Corcept Therapeutics (CORT) United States $2.381B 24.21
Dyne Therapeutics (DYN) United States $2.139B 0.00
PTC Therapeutics (PTCT) United States $1.927B 0.00
Catalyst Pharmaceuticals (CPRX) United States $1.888B 19.51
Fusion Pharmaceuticals (FUSN) Canada $1.803B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $1.790B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.753B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.676B 9.93
Avadel Pharmaceuticals (AVDL) Ireland $1.629B 0.00
Taro Pharmaceutical Industries (TARO) Israel $1.588B 27.79
Ardelyx (ARDX) United States $1.524B 0.00
4D Molecular Therapeutics (FDMT) United States $1.294B 0.00
Pacira BioSciences (PCRX) United States $1.245B 12.39
Soleno Therapeutics (SLNO) United States $1.230B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.197B 11.25
Xencor (XNCR) United States $1.166B 0.00
Collegium Pharmaceutical (COLL) United States $1.159B 7.13
Ocular Therapeutix (OCUL) United States $1.127B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.081B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.944B 0.00
Cronos Group (CRON) Canada $0.924B 0.00
Cassava Sciences (SAVA) United States $0.920B 0.00
ARS Pharmaceuticals (SPRY) United States $0.874B 0.00
USANA Health Sciences (USNA) United States $0.828B 13.03
Relay Therapeutics (RLAY) United States $0.815B 0.00
Enliven Therapeutics (ELVN) United States $0.810B 0.00
Sage Therapeutics (SAGE) United States $0.756B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.710B 0.00
Savara (SVRA) United States $0.685B 0.00
ProKidney (PROK) United States $0.651B 0.00
Silence Therapeutics (SLN) United Kingdom $0.645B 0.00
Siga Technologies (SIGA) United States $0.605B 8.96
Lyell Immunopharma (LYEL) United States $0.605B 0.00
Verve Therapeutics (VERV) United States $0.564B 0.00
OmniAb (OABI) United States $0.560B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.558B 0.00
Korro Bio (KRRO) United States $0.556B 0.00
Exscientia (EXAI) United Kingdom $0.522B 0.00
Altimmune (ALT) United States $0.499B 0.00
KalVista Pharmaceuticals (KALV) United States $0.491B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.462B 0.00
Larimar Therapeutics (LRMR) United States $0.450B 0.00
Tourmaline Bio (TRML) United States $0.428B 0.00
Harrow (HROW) United States $0.418B 0.00
Heron Therapeutics (HRTX) United States $0.416B 0.00
Lexeo Therapeutics (LXEO) United States $0.404B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.390B 0.00
Bioventus (BVS) United States $0.372B 0.00
Organogenesis (ORGO) United States $0.368B 69.75
Nature's Sunshine Products (NATR) United States $0.354B 19.80
Esperion Therapeutics (ESPR) United States $0.349B 0.00
Lyra Therapeutics (LYRA) United States $0.323B 0.00
Fractyl Health (GUTS) United States $0.318B 0.00
ESSA Pharma (EPIX) Canada $0.313B 0.00
Metagenomi (MGX) United States $0.309B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.299B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.296B 0.00
Black Diamond Therapeutics (BDTX) United States $0.295B 0.00
Akebia Therapeutics (AKBA) United States $0.291B 0.00
Aquestive Therapeutics (AQST) United States $0.287B 0.00
Pyxis Oncology (PYXS) United States $0.281B 0.00
Adherex Technologies (FENC) United States $0.263B 0.00
Nanobiotix S.A (NBTX) France $0.254B 0.00
Telomir Pharmaceuticals (TELO) United States $0.251B 0.00
Xeris Biopharma Holdings (XERS) United States $0.250B 0.00
Nektar Therapeutics (NKTR) United States $0.248B 0.00
Foghorn Therapeutics (FHTX) United States $0.246B 0.00
Avita Medical (RCEL) United States $0.241B 0.00
Acrivon Therapeutics (ACRV) United States $0.234B 0.00
Aldeyra Therapeutics (ALDX) United States $0.234B 0.00
Prelude Therapeutics (PRLD) United States $0.230B 0.00
Conduit Pharmaceuticals (CDT) United States $0.216B 0.00
Innate Pharma SA (IPHYF) France $0.213B 0.00
Galectin Therapeutics (GALT) United States $0.209B 0.00
Zevra Therapeutics (ZVRA) United States $0.202B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.195B 0.00
Profound Medical (PROF) Canada $0.190B 0.00
Century Therapeutics (IPSC) United States $0.184B 0.00
MediWound (MDWD) Israel $0.166B 0.00
Karyopharm Therapeutics (KPTI) United States $0.159B 0.00
Achieve Life Sciences (ACHV) Canada $0.157B 0.00
Incannex Healthcare (IXHL) Australia $0.154B 0.00
Regulus Therapeutics (RGLS) United States $0.153B 0.00
VAXART, INC (VXRT) United States $0.151B 0.00
GlycoMimetics (GLYC) United States $0.147B 0.00
Elite Pharmaceuticals (ELTP) United States $0.145B 13.58
CytoDyn (CYDY) United States $0.145B 0.00
Relmada Therapeutics (RLMD) United States $0.141B 0.00
Inotiv (NOTV) United States $0.140B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.136B 2.86
Citius Pharmaceuticals (CTXR) United States $0.130B 0.00
FibroGen (FGEN) United States $0.125B 0.00
Eliem Therapeutics (ELYM) United States $0.123B 0.00
Cardiol Therapeutics (CRDL) Canada $0.119B 0.00
OptiNose (OPTN) United States $0.115B 0.00
ProPhase Labs (PRPH) United States $0.113B 0.00
Vivani Medical (VANI) United States $0.101B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.089B 0.00
Aclaris Therapeutics (ACRS) United States $0.087B 0.00
AlloVir (ALVR) United States $0.087B 0.00
ARYA Sciences Acquisition Corp IV (ARYD) United States $0.085B 0.00
PMV Pharmaceuticals (PMVP) United States $0.083B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.079B 0.00
Journey Medical (DERM) United States $0.077B 0.00
Assertio Holdings (ASRT) United States $0.074B 6.00
Tempest Therapeutics (TPST) United States $0.073B 0.00
Carisma Therapeutics (CARM) United States $0.070B 0.00
Champions Oncology (CSBR) United States $0.068B 0.00
Mural Oncology (MURA) $0.064B 0.00
Reneo Pharmaceuticals (RPHM) United States $0.059B 0.00
SCYNEXIS (SCYX) United States $0.054B 0.80
Gain Therapeutics (GANX) United States $0.052B 0.00
BioLineRx (BLRX) Israel $0.050B 0.00
Jaguar Animal Health (JAGX) United States $0.046B 0.00
Rafael Holdings (RFL) United States $0.044B 0.00
Unicycive Therapeutics (UNCY) United States $0.040B 0.00
NRx Pharmaceuticals (NRXP) United States $0.040B 0.00
Natural Alternatives (NAII) United States $0.040B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.038B 0.00
Viracta Therapeutics (VIRX) United States $0.037B 0.00
VYNE Therapeutics (VYNE) United States $0.034B 0.00
ElectroCore (ECOR) United States $0.034B 0.00
Nutriband (NTRB) United States $0.033B 0.00
JanOne (JAN) United States $0.031B 0.00
Protara Therapeutics (TARA) United States $0.031B 0.00
CASI Pharmaceuticals (CASI) China $0.030B 0.00
Lipocine (LPCN) United States $0.028B 0.00
Enlivex Therapeutics (ENLV) Israel $0.027B 0.00
DURECT (DRRX) United States $0.027B 0.00
Aptorum Group (APM) United Kingdom $0.026B 0.00
CERo Therapeutics Holdings (CERO) United States $0.024B 0.00
Oncternal Therapeutics (ONCT) United States $0.024B 0.00
Iterum Therapeutics (ITRM) Ireland $0.024B 0.00
Addex Therapeutics (ADXN) Switzerland $0.023B 0.00
Indaptus Therapeutics (INDP) United States $0.023B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.022B 10.47
MEI Pharma (MEIP) United States $0.022B 1.11
TherapeuticsMD (TXMD) United States $0.022B 0.00
PolyPid (PYPD) Israel $0.021B 0.00
Alaunos Therapeutics (TCRT) United States $0.020B 0.00
Surrozen (SRZN) United States $0.019B 0.00
BioVie (BIVI) United States $0.019B 0.00
Nuvilex (PMCB) United States $0.018B 0.00
Minerva Neurosciences (NERV) United States $0.017B 0.00
Talphera (TLPH) United States $0.017B 0.00
Dominari Holdings (DOMH) United States $0.017B 0.00
Mannatech (MTEX) United States $0.015B 0.00
Traws Pharma (TRAW) United States $0.014B 0.00
Avalo Therapeutics (AVTX) United States $0.014B 0.00
Inhibikase Therapeutics (IKT) United States $0.014B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.013B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.013B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.013B 0.00
Biomerica (BMRA) United States $0.013B 0.00
Redhill Biopharma (RDHL) Israel $0.011B 0.00
Cosmos Health (COSM) Greece $0.011B 0.00
Molecular Templates (MTEM) United States $0.008B 0.00
Plus Therapeutics (PSTV) United States $0.008B 0.00
Clever Leaves Holdings (CLVR) Canada $0.007B 0.00
Universe Pharmaceuticals INC (UPC) China $0.007B 0.00
Vivos Therapeutics (VVOS) United States $0.007B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.007B 0.00
Mangoceuticals (MGRX) United States $0.007B 0.00
Ainos (AIMD) United States $0.006B 0.00
XORTX Therapeutics (XRTX) Canada $0.006B 0.00
Avenue Therapeutics (ATXI) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Acutus Medical (AFIB) United States $0.005B 0.00
MyMD Pharmaceuticals (MYMD) United States $0.005B 0.00
Heatwurx (PCSA) United States $0.005B 0.00
Petros Pharmaceuticals (PTPI) United States $0.005B 0.00
SHINECO (SISI) China $0.004B 0.00
Finch Therapeutics (FNCH) United States $0.004B 0.00
Phio Pharmaceuticals (PHIO) United States $0.003B 0.00
TransCode Therapeutics (RNAZ) United States $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.003B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.003B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.002B 0.00
Bio-Path Holdings (BPTH) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Qualigen Therapeutics (QLGN) United States $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
InMed Pharmaceuticals (INM) Canada $0.002B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
Aditxt (ADTX) United States $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.001B 0.00
Qilian Holding Group (QLI) China $0.000B 0.00
Context Therapeutics (CNTX) United States $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 5.15
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 46.55